Outcomes of Induction Chemotherapy Plus Intensity-Modulated Radiotherapy (IMRT) Versus IMRT Plus Concurrent Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma: A Propensity Matched Study

Outcomes of Induction Chemotherapy Plus Intensity-Modulated Radiotherapy (IMRT) Versus IMRT Plus Concurrent Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma: A Propensity Matched Study

PURPOSE: It deserves investigation whether induction chemotherapy (IC) followed by intensity-modulated radiotherapy (IMRT) is inferior to the current standard of IMRT plus concurrent chemotherapy (CC) in locoregionally advanced nasopharyngeal carcinoma. METHODS: Patients who received IC (94 patients...

Bibliografski detalji
Glavni autori:	Pu-Yun OuYang, Zhuo-Fei Bi, Lu-Ning Zhang, Kai-Yun You, Yao Xiao, Xiao-Wen Lan, Jie Tang, Xi-Cheng Wang, Wuguo Deng, Fang-Yun Xie
Format:	Članak
Jezik:	English
Izdano:	Elsevier 2016-08-01
Serija:	Translational Oncology
Online pristup:	http://www.sciencedirect.com/science/article/pii/S1936523316300614

Slični predmeti

Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study
od: Wen-Ze Qiu, i dr.
Izdano: (2016-01-01)

Deletion of concurrent chemotherapy on the basis of sequential chemoradiotherapy for non‐metastatic stage T4 nasopharyngeal carcinoma in IMRT era
od: Yuming Zheng, i dr.
Izdano: (2024-02-01)

The Clinical Outcomes and Toxicities of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
od: Rui Zou, i dr.
Izdano: (2021-02-01)

Induction Chemotherapy Has No Prognostic Value in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma and Chronic Hepatitis B Infection in the IMRT Era
od: Lu-Lu Zhang, i dr.
Izdano: (2017-10-01)

Ten-Year Outcomes Of Intensity-Modulated Radiotherapy (IMRT) Combine With Chemotherapy Versus IMRT Alone For Stage II Nasopharyngeal Carcinoma In The Real-World Study (RWD)
od: Ding XC, i dr.
Izdano: (2019-10-01)

Clinical Observation of Concurrent Radio-Chemotherapy Combined with Adjuvant Chemotherapy in Treating Locoregionally Advanced Nasopharyngeal Carcinoma
od: Yan-ping CHEN, Yun-cong LIU, i dr.
Izdano: (2010-02-01)

Induction chemotherapy followed by radiotherapy concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma
od: Li-Ting Liu, i dr.
Izdano: (2020-06-01)

Anti-programmed death-1 inhibitors and nimotuzumab in combination with induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis
od: Ya-Ni Zhang, i dr.
Izdano: (2025-01-01)

Whether Primary Bone‐Only Oligometastatic Nasopharyngeal Carcinoma Patients Benefit From Radiotherapy to the Bones on the Basis of Palliative Chemotherapy Plus Locoregional Radiotherapy?—A Large‐Cohort Retrospective Study
od: Wan‐Ping Guo, i dr.
Izdano: (2024-11-01)

A comparison of neoadjuvant chemotherapy with gemcitabine versus docetaxel plus cisplatin in locoregionally advanced nasopharyngeal carcinoma: a propensity score matching analysis
od: Liu T, i dr.
Izdano: (2018-11-01)

Efficacy of adjuvant chemotherapy/maintenance chemotherapy after induction chemotherapy and concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Experiences of two centers
od: Hao‐Yun Tao, i dr.
Izdano: (2023-03-01)

Successful IMRT and concurrent chemotherapy for a patient with intrathoracic extensive‐stage small cell lung cancer
od: Yoshitsugu Horio, i dr.
Izdano: (2022-04-01)

Optimizing induction chemotherapy regimens for radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
od: Ying Li, i dr.
Izdano: (2023-04-01)

Dosimetric comparison of the simultaneous integrated boost in whole-breast irradiation after breast-conserving surgery: IMRT, IMRT plus an electron boost and VMAT.
od: Sangang Wu, i dr.
Izdano: (2015-01-01)

Cost-effectiveness analysis (CEA) of IMRT plus C12 boost vs IMRT only in adenoid cystic carcinoma (ACC) of the head and neck
od: A D Jensen, i dr.
Izdano: (2019-11-01)

Induction chemotherapy plus nimotuzumab followed by concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma
od: Xinmao Song, i dr.
Izdano: (2019-07-01)

Simultaneous dose distribution and fluence prediction for nasopharyngeal carcinoma IMRT
od: Yongbao Li, i dr.
Izdano: (2023-07-01)

Long-term outcomes of induction chemotherapy followed by concurrent chemoradiotherapy and adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective study
od: Xiaoyan Zhao, i dr.
Izdano: (2024-11-01)

MRI-based random survival Forest model improves prediction of progression-free survival to induction chemotherapy plus concurrent Chemoradiotherapy in Locoregionally Advanced nasopharyngeal carcinoma
od: Wei Pei, i dr.
Izdano: (2022-07-01)

Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
od: Wen-Fei Li, i dr.
Izdano: (2016-11-01)

Tislelizumab plus neoadjuvant chemotherapy and concurrent chemoradiotherapy versus neoadjuvant chemotherapy and concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: A retrospective study
od: Jiaqi He, i dr.
Izdano: (2024-10-01)

Induction chemotherapy plus camrelizumab combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma in non-endemic areas: a phase 2 clinical trial in North China
od: Zhongqiu Wang, i dr.
Izdano: (2025-02-01)

Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis
od: Jun-Fang Liao, i dr.
Izdano: (2019-06-01)

Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma
od: Lin Kong, i dr.
Izdano: (2016-12-01)

The impairment of induction chemotherapy for stage II nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy with or without concurrent chemotherapy: A propensity score‐matched analysis
od: YuLin Lai, i dr.
Izdano: (2023-02-01)

Comparison of Gemcitabine Plus Cisplatin vs. Docetaxel Plus Fluorouracil Plus Cisplatin Palliative Chemotherapy for Metastatic Nasopharyngeal Carcinoma
od: Xue-Song Sun, i dr.
Izdano: (2020-08-01)

Image-guided IMRT /
od: Bortfeld, Thomas
Izdano: (2006)

Dosimetric comparison of standard three-dimensional conformal radiotherapy followed by intensity-modulated radiotherapy boost schedule (sequential IMRT plan) with simultaneous integrated boost-IMRT (SIB IMRT) treatment plan in patients with localized carcinoma prostate
od: A Bansal, i dr.
Izdano: (2012-01-01)

Induction chemotherapy regimen of docetaxel plus cisplatin versus docetaxel, cisplatin plus fluorouracil followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Preliminary results of an open-label, noninferiority, multicentre, randomised, controlled phase 3 trial
od: Yan Wang, i dr.
Izdano: (2022-11-01)

Influence of beamlet width on dynamic IMRT plan quality in nasopharyngeal carcinoma
od: Manya Wu, i dr.
Izdano: (2022-08-01)

Concurrent chemotherapy using taxane plus cisplatin cisplatin alone in high-risk nasopharyngeal carcinoma patients with suboptimal response to induction chemotherapy
od: Ya-Ni Zhang, i dr.
Izdano: (2023-06-01)

Dosimetric and radiobiological comparison of simultaneous integrated boost radiotherapy for early stage right side breast cancer between three techniques: IMRT, hybrid IMRT and hybrid VMAT
od: Suyan Bi, i dr.
Izdano: (2022-03-01)

Application of Diffusion Kurtosis Imaging in Evaluating Acute Xerostomia in Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent Chemoradiotherapy
od: Da-Wei Zhao, i dr.
Izdano: (2022-05-01)

Concurrent chemotherapy for T4 classification nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.
od: Cai-neng Cao, i dr.
Izdano: (2015-01-01)

Is IMRT Superior or Inferior to 3DCRT in Radiotherapy for NSCLC? A Meta-Analysis.
od: Xingsheng Hu, i dr.
Izdano: (2016-01-01)

Dynamic Changes in Cognitive Function in Patients With Radiation-Induced Temporal Lobe Necrosis After IMRT for Nasopharyngeal Cancer
od: PeiYao Liu, i dr.
Izdano: (2020-04-01)

The immune modulation effects of gemcitabine plus cisplatin induction chemotherapy in nasopharyngeal carcinoma
od: Xiao‐Min Li, i dr.
Izdano: (2022-09-01)

The long-term survival of patients with III-IVb stage nasopharyngeal carcinoma treated with IMRT with or without Nimotuzumab: a propensity score-matched analysis
od: Wang Zhi-Qiang, i dr.
Izdano: (2019-11-01)

A detailed dosimetric comparative study of IMRT and VMAT in normal brain tissues for nasopharyngeal carcinoma patients treated with radiotherapy
od: Kainan Shao, i dr.
Izdano: (2023-05-01)

Chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Who really needs it
od: Weiling Qu, i dr.
Izdano: (2023-03-01)